Search

everythinglearnresearchcommunity

for

Search:↓

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

A woman's COVID-19 related hair loss improved after using a specific hair care routine for 30 days.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

New cell-based therapies may improve hair loss treatments in the future.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Chitrak is a medicinal plant with health benefits like fighting microbes, reducing inflammation, and promoting hair growth, but it can be toxic and needs more research.

New genes linked to male pattern baldness were found on chromosome 20p11.

Spironolactone can effectively treat hair loss with manageable side effects.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Topical retinoids effectively improve photodamaged skin.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Humans and pets share similar allergy mechanisms, and studying pet allergies can help treat both human and animal allergies.

Finasteride effectively treats hair loss in transgender men with few side effects.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

Non-drug therapies show promise for hair regrowth but need more research.

Hemp-derived cannabinoids can benefit skin and hair without causing a high.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Low-Level Laser Therapy might be a good alternative for hair loss when other treatments fail, but its effectiveness varies and more research is needed.

Extracts improve hair growth in alopecia.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.